Paydirt
PM
Insider

Paul A Mahon

EVP & GENERAL COUNSEL

Paul A Mahon (EVP & GENERAL COUNSEL) filed 24 Form 4 reports in the trailing twelve months (0 purchases, 24 sales), most often in United Therapeutics Corporation (UTHR). The largest single filing was $5.5M of UTHR (10,742 sh across 4 lots, as filed), executed Dec 24 2025.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
returns measure stock purchases only
Filings, ttm
24
0 buys · 24 sells
Median delay
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$109.0M
shares × price, as filed
Last traded
Sep 17
Filed Sep 18

Median ADV $265.8M across their filed names

Open performance
Volume by month
$14.5M$7.3M$0Oct 2024Apr 2025Oct 2025Apr 2026Nov 2024 · sells $2.8MDec 2024 · sells $2.9MApr 2025 · sells $6.4MMay 2025 · sells $9.7MJun 2025 · sells $6.1MJul 2025 · sells $6.6MAug 2025 · sells $6.6MSep 2025 · sells $8.6MOct 2025 · sells $14.5MNov 2025 · sells $10.4MDec 2025 · sells $10.8MJan 2026 · sells $7.8MFeb 2026 · sells $8.0MMar 2026 · sells $8.3MApr 2026 · sells $9.5MMay 2026 · sells $9.4MJun 2026 · sells $8.9MJul 2026 · sells $8.9MAug 2026 · sells $8.6MSep 2026 · sells $4.1M
Buys $0 Sells $158.8M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 24 filings

Sector per market data · by filing · past 12 months

Most traded names
UTHR United Therapeutics Corporation UTHR · 0 buys · 39 sells 39 filings
Recent filings
UTHRSALE United Therapeutics Corporation View filing → $4.8M
8,150 sh across 6 lots
Exec May 7
Filed May 7 · 5:30 PM ET
UTHRSALE United Therapeutics Corporation View filing → $4.8M
8,300 sh across 5 lots
Exec Apr 16
Filed Apr 16 · 5:30 PM ET
UTHRSALE United Therapeutics Corporation View filing → $4.7M
8,300 sh across 11 lots
Exec Apr 2
Filed Apr 2 · 5:30 PM ET
UTHRSALE United Therapeutics Corporation View filing → $4.4M
8,220 sh across 6 lots
Exec Mar 19
Filed Mar 19 · 5:30 PM ET
UTHRSALE United Therapeutics Corporation View filing → $3.9M
8,100 sh across 8 lots
Exec Mar 5
Filed Mar 5 · 5:30 PM ET
UTHRSALE United Therapeutics Corporation View filing → $4.0M
8,300 sh across 8 lots
Exec Feb 19
Filed Feb 19 · 5:30 PM ET
UTHRSALE United Therapeutics Corporation View filing → $4.0M
8,300 sh across 6 lots
Exec Feb 5
Filed Feb 5 · 5:30 PM ET
UTHRSALE United Therapeutics Corporation View filing → $3.9M
8,260 sh across 5 lots
Exec Jan 15
Filed Jan 15 · 5:30 PM ET
More filings →